Tilia Fiduciary Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$735K Sell
3,007
-62
-2% -$14.4K 0.4% 64
2025
Q4
$635K Buy
3,069
+77
+3% +$15.2K 0.35% 68
2025
Q3
$555K Sell
2,992
-19
-0.6% -$3.25K 0.32% 71
2025
Q2
$460K Sell
3,011
-41
-1% -$6.3K 0.28% 76
2025
Q1
$506K Sell
3,052
-103
-3% -$16.1K 0.34% 74
2024
Q4
$456K Sell
3,155
-75
-2% -$11.6K 0.31% 75
2024
Q3
$523K Buy
3,230
+89
+3% +$14.2K 0.36% 67
2024
Q2
$459K Sell
3,141
-564
-15% -$83.9K 0.36% 68
2024
Q1
$586K Buy
3,705
+297
+9% +$47.3K 0.48% 61
2023
Q4
$534K Buy
3,408
+60
+2% +$9.2K 0.5% 63
2023
Q3
$521K Buy
3,348
+87
+3% +$14.4K 0.54% 62
2023
Q2
$540K Sell
3,261
-92
-3% -$14.8K 0.48% 60
2023
Q1
$520K Sell
3,353
-119
-3% -$19.2K 0.5% 61
2022
Q4
$613K Buy
3,472
+6
+0.2% +$1.04K 0.59% 56
2022
Q3
$564K Sell
3,466
-116
-3% -$19.6K 0.57% 56
2022
Q2
$630K Buy
3,582
+162
+5% +$28.9K 0.6% 53
2022
Q1
$606K Buy
3,420
+51
+2% +$8.68K 0.51% 57
2021
Q4
$576K Buy
+3,369
New +$552K 0.46% 68

Other funds holding JNJ

Tilia Fiduciary Partners's JNJ Position: Q1 2026 in Review

Tilia Fiduciary Partners reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $14.4K and leaving 3,007 shares worth $735K. The position accounts for 0.4% of the portfolio, ranked #64.

Tilia Fiduciary Partners first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,622 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tilia Fiduciary Partners held 3,007 shares of Johnson & Johnson worth $735K as of Q1 2026.
  • Tilia Fiduciary Partners sold 62 Johnson & Johnson shares in Q1 2026, an estimated $14.4K.
  • Johnson & Johnson made up 0.4% of Tilia Fiduciary Partners's portfolio in Q1 2026, its #64 holding.
  • Tilia Fiduciary Partners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tilia Fiduciary Partners's 13F filing for Q1 2026, filed 9 Apr 2026.